Hormones in the Treatment of Depression

Soares, Cláudio N.; Phillips, Shauna Dae

doi:10.2217/17455057.2.3.435

Cited by 1 publication

(1 citation statement)

References 91 publications

(105 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus it is possible that individual formulations may confer differential mood effects. In previous reports in women without bipolar disorder, specific HT formulations have shown distinctive influences on mood, such as the antidepressant efficacy of transdermal estradiol in depressed perimenopausal women (54, 55).…”

Section: Discussionmentioning

confidence: 99%

Progression of female reproductive stages associated with bipolar illness exacerbation

et al. 2012

View full text Add to dashboard Cite

Objectives Late perimenopause and early postmenopause confer an increased risk of depression in the population, yet bipolar disorder mood course during these times remains unclear. Methods Clinic visits in 519 premenopausal, 116 perimenopausal including 13 women transitioning from perimenopause to postmenopause, and 133 postmenopausal women with bipolar disorder who received naturalistic treatment in the multisite STEP-BD study over 19.8±15.5 months were analyzed for mood state. History of postpartum and perimenstrual mood exacerbation and current hormone therapy were evaluated as potential mood predictors. Results A progression in female reproductive stage (premenopause, perimenopause, and postmenopausae) was significantly associated with percent of visits decreasing in euthymia (29.3%, 27.0%, 25.0%, respectively, p<0.05) decreasing in syndromal mood elevation (5.3%, 4.1%, and 3.0%, respectively, p<0.001), and increasing in subsyndromal symptoms (47.3%, 50.7%, and 52.7%, respectively, p = 0.05). Thirteen women transitioning from peri- to postmenopause had a significantly greater proportion of visits in syndromal depression (24.4%, p<0.0005) compared to premenopausal, perimenopausal and postmenopausal women, while depression in the latter three groups (18.1%, 18.1%, and 19.3%, respectively) did not differ. Perimenstrual and/or postpartum mood exacerbation, or hormone therapy did not significantly alter depression during perimenopause. Conclusions A progression in female reproductive stages was associated with bipolar illness exacerbation. A small number of women transitioning from perimenopause to postmenopause had significantly greater depression than other female reproductive groups. Euthymia and mood elevation decreased with progressing female reproductive stage. Menstrual cycle or postpartum mood exacerbation, or current hormone therapy use, was not associated with perimenopausal depression. Future studies, which include hormonal assessments, are needed to confirm these preliminary findings.

show abstract

Section: Discussionmentioning

confidence: 99%